BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 22147843)

  • 1. Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments.
    Worbe Y; Palminteri S; Hartmann A; Vidailhet M; Lehéricy S; Pessiglione M
    Arch Gen Psychiatry; 2011 Dec; 68(12):1257-66. PubMed ID: 22147843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
    Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
    Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole in patients with Tourette syndrome.
    Bubl E; Perlov E; Tebartz Van Elst L
    World J Biol Psychiatry; 2006; 7(2):123-5. PubMed ID: 16684686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-dependent reinforcement of motor skill learning: evidence from Gilles de la Tourette syndrome.
    Palminteri S; Lebreton M; Worbe Y; Hartmann A; Lehéricy S; Vidailhet M; Grabli D; Pessiglione M
    Brain; 2011 Aug; 134(Pt 8):2287-301. PubMed ID: 21727098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial magnetic stimulation in Gilles de la Tourette syndrome.
    Orth M
    J Psychosom Res; 2009 Dec; 67(6):591-8. PubMed ID: 19913663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tics and Gilles de la Tourette syndrome].
    Tijero-Merino B; Gómez-Esteban JC; Zarranz JJ
    Rev Neurol; 2009 Jan; 48 Suppl 1():S17-20. PubMed ID: 19222010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a primate model of Gilles de la Tourette syndrome: anatomo-behavioural correlation of disorders induced by striatal dysfunction.
    Worbe Y; Sgambato-Faure V; Epinat J; Chaigneau M; Tandé D; François C; Féger J; Tremblay L
    Cortex; 2013 Apr; 49(4):1126-40. PubMed ID: 23040317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients.
    Kawohl W; Schneider F; Vernaleken I; Neuner I
    World J Biol Psychiatry; 2009; 10(4 Pt 3):827-31. PubMed ID: 18843565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional immaturity of cortico-basal ganglia networks in Gilles de la Tourette syndrome.
    Worbe Y; Malherbe C; Hartmann A; Pélégrini-Issac M; Messé A; Vidailhet M; Lehéricy S; Benali H
    Brain; 2012 Jun; 135(Pt 6):1937-46. PubMed ID: 22434213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome.
    Salvador A; Worbe Y; Delorme C; Coricelli G; Gaillard R; Robbins TW; Hartmann A; Palminteri S
    Sci Rep; 2017 Jul; 7(1):6292. PubMed ID: 28740149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of control: decreased motor cortex engagement during a Go/NoGo task in Tourette's syndrome.
    Thomalla G; Jonas M; Bäumer T; Siebner HR; Biermann-Ruben K; Ganos C; Orth M; Hummel FC; Gerloff C; Müller-Vahl K; Schnitzler A; Münchau A
    Brain; 2014 Jan; 137(Pt 1):122-36. PubMed ID: 24176975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple tics and Gilles de la Tourette syndrome].
    Müller K
    Monatsschr Kinderheilkd; 1991 Jun; 139(6):330-5. PubMed ID: 1680219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gilles de la tourette syndrome: clinical spectrum and management].
    Calderón González R; Calderón Sepúlveda RF
    Rev Neurol; 2003 Apr 1-15; 36(7):679-88. PubMed ID: 12666050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptual-motor skill learning in Gilles de la Tourette syndrome. Evidence for multiple procedural learning and memory systems.
    Marsh R; Alexander GM; Packard MG; Zhu H; Peterson BS
    Neuropsychologia; 2005; 43(10):1456-65. PubMed ID: 15989936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome.
    Cavanna AE; David K; Orth M; Robertson MM
    Eur J Paediatr Neurol; 2012 Nov; 16(6):605-12. PubMed ID: 22381812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole for the treatment of adolescent Tourette's syndrome: a case report.
    Lewis K; Rappa L; Sherwood-Jachimowicz DA; Larose-Pierre M
    J Pharm Pract; 2010 Jun; 23(3):239-44. PubMed ID: 21507820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Somatosensory phenomena and the role of sensorimotor circuits in Gilles de la Tourette syndrome].
    Münchau A; Thomalla G; Roessner V
    Z Kinder Jugendpsychiatr Psychother; 2011 May; 39(3):161-7; quiz 168-9. PubMed ID: 21563107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine in Gilles de la Tourette syndrome: beyond tics.
    Van den Eynde F; Naudts KH; De Saedeleer S; van Heeringen C; Audenaert K
    Acta Neurol Belg; 2005 Dec; 105(4):206-11. PubMed ID: 16482870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Gilles de la Tourette syndrome: the current status.
    Robertson MM
    Arch Dis Child Educ Pract Ed; 2012 Oct; 97(5):166-75. PubMed ID: 22440810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.